Journal Mobile Options
Table of Contents
Vol. 41, No. 5, 2008
Issue release date: August 2008
Psychopathology 2008;41:322–329

First-Episode Psychosis: Diagnostic Stability over One and Two Years

Haahr U. · Friis S. · Larsen T.K. · Melle I. · Johannessen J.O. · Opjordsmoen S. · Simonsen E. · Rund B.R. · Vaglum P. · McGlashan T.
aPsychiatric Research Unit, Zealand Region Psychiatry Roskilde, Roskilde, Denmark; bUllevaal University Hospital and Departments of cPsychiatry, dPsychology, and eBehavioral Sciences in Medicine, University of Oslo, Oslo, fStavanger University Hospital, Haugesund Hospital, Stavanger, Norway; gDepartment of Psychiatry, Yale University, New Haven, Conn., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Diagnostic stability is important for daily clinical work and planning of treatment. The aims of this study were to measure diagnostic stability in a clinical epidemiologic sample and to identify markers of change in diagnosis. Sampling and Methods: Diagnostic stability and change were measured in a sample of 301 patients with first-episode psychosis from four national health care sectors in Norway and Denmark at baseline, 1 and 2 years. Results: Diagnostic stabilities were high for schizophrenia and schizoaffective disorder (85–99%), low for schizophreniform disorder (16–19%), and intermediate for other diagnoses. Diagnostic change from schizophreniform to schizophrenia was frequent in year 1 (72%). Characteristics discriminating schizophreniform patients keeping their diagnosis (i.e. having recovered within 6 months with no relapse) from those developing schizophrenia at 1 year were female gender, better childhood premorbid functioning, shorter duration of untreated psychosis and more severe general psychotic symptoms, especially excitation. Conclusions: Findings provide validation for the DSM-IV categories within the schizophrenic spectrum. The limitations of the study were: the raters were not blind to baseline assessments; patients with longer duration of untreated psychosis were more likely to refuse participation; not all patients were assessed at 1- and 2-year follow-up, but the attrition was rather low.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Schwartz JE, Fennig S, Tanenberg-Karant M, Carlson G, Craig T, Galambos N, Lavelle J, Bromet EJ: Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch Gen Psychiatry 2000;57:593–600.
  2. Tsuang MT, Woolson RF, Winokur G, Crowe RR: Stability of psychiatric diagnosis. Schizophrenia and affective disorders followed up over a 30- to 40-year period. Arch Gen Psychiatry 1981;38:535–539.
  3. Chen YR, Swann AC, Burt DB: Stability of diagnosis in schizophrenia. Am J Psychiatry 1996;153:682–686.
  4. Huguelet P, Schneider El Gueddari N, Glauser D: Stability of DSM-III-R diagnoses: study of a case register. Psychopathology 2001;34:118–122.
  5. Munk-Jorgensen P: The schizophrenia diagnosis in Denmark. A register-based investigation. Acta Psychiatr Scand 1985;72:266–273.
  6. Jorgensen P, Mortensen PB: Admission pattern and diagnostic stability of patients with functional psychoses in Denmark during a two-year observation period. Acta Psychiatr Scand 1988;78:361–365.
  7. Fennig S, Kovasznay B, Rich C, Ram R, Pato C, Miller A, Rubinstein J, Carlson G, Schwartz JE, Phelan J: Six-month stability of psychiatric diagnoses in first-admission patients with psychosis. Am J Psychiatry 1994;151:1200–1208.
  8. Forrester A, Owens DG, Johnstone EC: Diagnostic stability in subjects with multiple admissions for psychotic illness. Psychol Med 2001;31:151–158.
  9. Naz B, Bromet EJ, Mojtabai R: Distinguishing between first-admission schizophreniform disorder and schizophrenia. Schizophr Res 2003;62:51–58.
  10. Veen ND, Selten JP, Schols D, Laan W, Hoek HW, van der Tweel I, Kahn RS: Diagnostic stability in a Dutch psychosis incidence cohort. Br J Psychiatry 2004;185:460–464.
  11. Opjordsmoen S: Long-term course and outcome in delusional disorder. Acta Psychiatr Scand 1988;78:576–586.
  12. Opjordsmoen S: Delusional disorders. I. Comparative long-term outcome. Acta Psychiatr Scand 1989;80:603–612.
  13. Marneros A, Deister A, Rohde A: Stability of diagnoses in affective, schizoaffective and schizophrenic disorders. Cross-sectional versus longitudinal diagnosis. Eur Arch Psychiatry Clin Neurosci 1991;241:187–192.
  14. Naz B, Bromet EJ, Mojtabai R: Distinguishing between first-admission schizophreniform disorder and schizophrenia. Schizophr Res 2003;62:51–58.
  15. Veen ND, Selten JP, Schols D, Laan W, Hoek HW, van der Tweel I, Kahn RS: Diagnostic stability in a Dutch psychosis incidence cohort. Br J Psychiatry 2004;185:460–464.
  16. Schimmelmann BG, Conus P, Edwards J, McGorry PD, Lambert M: Diagnostic stability 18 months after treatment initiation for first-episode psychosis. J Clin Psychiatry 2005;66:1239–1246.
  17. American Psychiatric Association: DSM-III-R. Diagnostic and Statistical Manual of Psychiatric Disorders, ed 3, revised. Washington, American Psychiatric Association Press, 1987.
  18. Lehman AF, Steinwachs DM: Evidence-based psychosocial treatment practices in schizophrenia: lessons from the patient outcomes research team (PORT) project. J Am Acad Psychoanal Dyn Psychiatry 2003;31:141–154.
  19. Friis S, Larsen TK, Melle I, Opjordsmoen S, Johannessen JO, Haahr U, Simonsen E, Rund BR, Vaglum P, McGlashan T: Methodological pitfalls in early detection studies – the NAPE Lecture 2002. Nordic Association for Psychiatric Epidemiology. Acta Psychiatr Scand 2003;107:3–9.
  20. First MB, Spitzer RL, Gibbon M, Williams JBW: Structural Clinical Interview for DSM-IV Axis I Disorders – Patient Edition (SCID I/P, version 2.0). New York, New York State Psychiatric Institute, 1995.
  21. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–276.
  22. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS: Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990;16:57–67.
  23. Cannon-Spoor HE, Potkin SG, Wyatt RJ: Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982;8:470–484.
  24. Larsen TK, Friis S, Haahr U, Johannessen JO, Melle I, Opjordsmoen S, Rund BR, Simonsen E, Vaglum PV, McGlashan TH: Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course. Br J Psychiatry 2004;185:108–115.
  25. Bentsen H, Munkvold OG, Notland TH, Boye B, Bjørge H, Lersbryggen AB, Oskarsson KH, Berg-Larsen R, Malt UF: The interrater reliability of the Positive and Negative Syndrome Scale (PANSS). Int J Methods Psychiatr Res 1996;6:227–235.

    External Resources

  26. Friis S, Melle I, Larsen TK, Haahr U, Johannessen JO, Simonsen E, Opjordsmoen S, Vaglum P, McGlashan TH: Does duration of untreated psychosis bias study samples of first-episode psychosis? Acta Psychiatr Scand 2004;110:286–291.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50